1.The use of complementary and alternative medicine in chronic pain patients in Singapore: a single-centre study.
Michelle G E TAN ; Ma Thin WIN ; Shariq Ali KHAN
Annals of the Academy of Medicine, Singapore 2013;42(3):133-137
INTRODUCTIONThe use of complementary and alternative medicine (CAM) in Singapore for a variety of conditions has been reported to be high. However in Asian chronic pain patients, there is no data on their use of CAM and its perceived benefits.
MATERIALS AND METHODSA cross-sectional survey of 210 patients was carried out in Pain Management Centre. Patients were interviewed directly on their use of CAM. The outcomes were prevalence of CAM use, the types of CAM used, the perceived efficacy and factors influencing its use.
RESULTSThe prevalence of CAM users in chronic pain is 84%. The most common class of CAM is traditional Chinese medicine (68%) the subset of which, acupuncture, was most frequently utilised (49% of patients using CAM). In univariate analyses, ethnicity was significantly linked to CAM use but not gender, age, education level and income (P = 0.027). Specifically for neck pain, it was significant that patients were more likely to see a chiropractor, to use massage, to take take vitamins and ginseng to alleviate their symptoms. With upper limb pain, it was the use of Tui na, massage and seeing a TCM practitioner. For abdominal pain, it was the use of herbal medicines. The majority felt that CAM helped with their pain (72%) although less expressed satisfaction with CAM (64%). Reasons for using CAM included: having more control over their pain; fewer side effects; safety and lower costs compared to conventional medicine.
CONCLUSIONThe use of CAM in chronic pain patients is higher than the general population. Most felt that it improved their pain. As part of multimodal therapy, CAM may have a role in the management of chronic pain.
Adolescent ; Adult ; Chronic Pain ; therapy ; Complementary Therapies ; utilization ; Female ; Humans ; Male ; Middle Aged ; Singapore ; Socioeconomic Factors ; Young Adult
2.Efficacy of SG Shield in reducing droplet contamination during collection of oropharyngeal swab culture specimens.
Phui-Sze Angie AU-YONG ; Xuanxuan CHEN ; Wen Hao LOW ; Keen Chong CHAU ; Stephanie FOOK-CHONG ; Shariq Ali KHAN
Singapore medical journal 2022;63(9):509-513
INTRODUCTION:
Oropharyngeal swabs for diagnosis of COVID-19 often induce violent coughing, which can disperse infectious droplets onto providers. Incorrectly doffing personal protective equipment (PPE) increases the risk of transmission. A cheap, single-use variation of the face shield invented by a Singaporean team, SG Shield, aims to reduce this risk. This manikin study aimed to study the efficacy of the SG Shield in combination with standard PPE.
METHODS:
A person attired in full PPE whose face and chest was lined with grid paper stood in front of an airway manikin in an enclosed room. A small latex balloon containing ultraviolet fluorescent dye was placed in the oral cavity of the manikin and inflated until explosion to simulate a cough. Three study groups were tested: (a) control (no shield), (b) face shield and (c) SG Shield. The primary outcome was droplet dispersion, determined quantitatively by calculating the proportion of grid paper wall squares stained with fluorescent dye. The secondary outcome was the severity of provider contamination.
RESULTS:
The SG Shield significantly reduced droplet dispersion to 0% compared to the controls (99.0%, P = 0.001). The face shield also significantly reduced droplet contamination but to a lesser extent (80.0%) compared to the control group (P = 0.001). Although the qualitative severity of droplet contamination was significantly lower in both groups compared to the controls, the face shield group had more contamination of the provider's head and neck.
CONCLUSION
The manikin study showed that the SG Shield significantly reduces droplet dispersion to the swab provider's face and chest.
Humans
;
Infectious Disease Transmission, Patient-to-Professional/prevention & control*
;
COVID-19
;
Fluorescent Dyes
;
Personal Protective Equipment
;
Cough